Veradigm Inc. (NASDAQ:MDRX – Get Free Report)’s stock price gapped down before the market opened on Tuesday . The stock had previously closed at $10.75, but opened at $10.00. Veradigm shares last traded at $10.43, with a volume of 2,229 shares changing hands.
Wall Street Analyst Weigh In
Separately, StockNews.com began coverage on shares of Veradigm in a report on Tuesday, December 3rd. They issued a “hold” rating for the company. Three investment analysts have rated the stock with a hold rating and two have given a buy rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus target price of $11.75.
Get Our Latest Stock Analysis on MDRX
Veradigm Trading Down 1.4 %
Institutional Investors Weigh In On Veradigm
A hedge fund recently bought a new stake in Veradigm stock. Innealta Capital LLC bought a new position in shares of Veradigm Inc. (NASDAQ:MDRX – Free Report) during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm bought 3,974 shares of the software maker’s stock, valued at approximately $38,000.
About Veradigm
Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.
Featured Articles
- Five stocks we like better than Veradigm
- What is the Hang Seng index?
- Amazon’s Healthcare Gamble: A New Era of Medical Disruption
- Bank Stocks – Best Bank Stocks to Invest In
- Semiconductor Giant Synopsys Slides 14% — Time to Take Notice
- Roth IRA Calculator: Calculate Your Potential Returns
- Tesla’s Closes in on $400: From Laggard to Leader in 2024
Receive News & Ratings for Veradigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veradigm and related companies with MarketBeat.com's FREE daily email newsletter.